Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration
Published on: December 27, 2024
Sp1 phosphorylation by ATM downregulates BER and promotes cell elimination in response to persistent DNA damage
Sally C Fletcher1, Claudia P Grou1, Arnaud J Legrand1
1Department of Oncology, CRUK & MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.
Abstract:
ATM (ataxia-telangiectasia mutated) is a central molecule for DNA quality control. Its activation by DNA damage promotes cell-cycle delay, which facilitates DNA repair prior to replication. On the other hand, persistent DNA damage has been implicated in ATM-dependent cell death via apoptosis; however, the mechanisms underlying this process remain elusive. Here we find that, in response to persistent DNA strand breaks, ATM phosphorylates transcription factor Sp1 and initiates its degradation. We show that Sp1 controls expression of the key base excision repair gene XRCC1, essential for DNA strand break repair. Therefore, degradation of Sp1 leads to a vicious cycle that involves suppression of DNA repair and further aggravation of the load of DNA damage. This activates transcription of pro-apoptotic genes and renders cells susceptible to elimination via both apoptosis and natural killer cells. These findings constitute a previously unrecognized 'gatekeeper' function of ATM as a detector of cells with persistent DNA damage.
Insights
The ataxia-telangiectasia mutated (ATM) protein detects persistent DNA damage by degrading transcription factor Sp1. This prevents DNA repair, promoting cell death and acting as a crucial gatekeeper.
Area of Science:
- Molecular Biology
- Cellular Biology
- Genetics
Background:
- The ataxia-telangiectasia mutated (ATM) protein is vital for DNA quality control and cell cycle regulation following DNA damage.
- ATM activation typically facilitates DNA repair, but its role in ATM-dependent cell death due to persistent DNA damage is not fully understood.
Purpose of the Study:
- To elucidate the mechanisms by which ATM induces cell death in response to persistent DNA strand breaks.
- To identify the molecular players involved in ATM-mediated apoptosis and DNA damage aggravation.
Main Methods:
- Investigated ATM's interaction with transcription factor Sp1 upon DNA damage.
- Analyzed the impact of Sp1 phosphorylation and degradation on DNA repair gene expression.
- Assessed the downstream effects on apoptosis and cell susceptibility to elimination.
Main Results:
- ATM phosphorylates and triggers the degradation of transcription factor Sp1 when DNA strand breaks persist.
- Sp1 is crucial for regulating the expression of the base excision repair gene XRCC1.
- Sp1 degradation leads to suppressed DNA repair, increased DNA damage, and activation of pro-apoptotic genes.
Conclusions:
- ATM acts as a 'gatekeeper' by detecting persistent DNA damage through Sp1 degradation.
- This mechanism initiates a feedback loop that compromises DNA repair and promotes cell elimination via apoptosis and NK cells.
- Uncovers a novel pathway linking DNA damage detection, repair suppression, and programmed cell death.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
The Eukaryotic Promoter Region
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Elimination Kinetics: First-Order and Zero-Order
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is a drug's half-life, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...

